You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.

Category:

BCRF News x

Dr. Lori J. Pierce presents at ASCO's 2018 annual meeting.
Congratulations to our investigators who were recognized for their contributions
Tags:
A keyboard with one of the keys printed with the word "donate" and a heart
We may not be able to host in-person events, but there are many creative ways to show your support for research
Marathon runner on Team BCRF
Learn how you can become a Team BCRF runner in this year’s 26.2-mile race
Tags:
Dr. Martine Piccart talks to us about the power of collaboration in metastatic breast cancer research
Tags:
Four BCRF investigators received awards of distinction for their advancements in breast cancer research.
Tags:
Follow these research-backed tips to maintain a healthy lifestyle in 2020 and beyond.
Study sheds new light on the differences marking metastatic disease from primary tumor cells and the critical importance for the study of metastatic lesions
BCRF_Research_374

NEW YORK, NY – December 11, 2019 – The Breast Cancer Research Foundation (BCRF) announced $5 million in funding provided by Eli Lilly and Company to conduct investigator-initiated studies of the CDK4 & 6 inhibitor, Verzenio® (abemaciclib).

Raise money for lifesaving research this holiday season and throughout the new year.
BCRF attended the fifth annual Conquer Cancer Scientific and Career Development Retreat designed to empower early career researchers.